ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) /
The cash flow of ARCUTIS BIOTHERAPEUTICS, INC. over the past 8 years
Chart ARCUTIS BIOTHERAPEUTICS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2018–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, ARCUTIS BIOTHERAPEUTICS, INC.'s operating cash flow was -$5.63M and its capital expenditures $686K, leaving free cash flow of -$6.31M. Free cash flow was below zero in all 8 years shown. It ranged from -$258.05M in fiscal 2022 to -$6.31M in fiscal 2025. Capital expenditures were highest in fiscal 2021, at $995K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$5.63M | $686K | -$6.31M |
| 2024ended Dec 31, 2024 | -$112.16M | $143K | -$112.3M |
| 2023ended Dec 31, 2023 | -$247.06M | $428K | -$247.49M |
| 2022ended Dec 31, 2022 | -$257.71M | $333K | -$258.05M |
| 2021ended Dec 31, 2021 | -$174.63M | $995K | -$175.62M |
| 2020ended Dec 31, 2020 | -$113.03M | $321K | -$113.35M |
| 2019ended Dec 31, 2019 | -$42.84M | $295K | -$43.13M |
| 2018ended Dec 31, 2018 | -$14.09M | $0 | -$14.09M |
Fiscal years as ARCUTIS BIOTHERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ARCUTIS BIOTHERAPEUTICS, INC.
- The revenue of ARCUTIS BIOTHERAPEUTICS, INC.
- The profitability of ARCUTIS BIOTHERAPEUTICS, INC.
- The debt of ARCUTIS BIOTHERAPEUTICS, INC.
- All of ARCUTIS BIOTHERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- BYNDBEYOND MEAT, INC.
- BBWIBATH & BODY WORKS, INC.
- MTHMeritage Homes Corporation
- EWTXEdgewise Therapeutics, Inc.
- APLEAPPLE HOSPITALITY REIT, INC.
Not investment advice. This page shows what ARCUTIS BIOTHERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.